CHAMPIONS ONCOLOGY, INC. 8-K
Research Summary
AI-generated summary
Champions Oncology, Inc. Reports Q3 2026 Unaudited Results
What Happened
- Champions Oncology, Inc. (ticker: CSBR) filed a Form 8-K on March 12, 2026 reporting its unaudited financial results for the third quarter ended January 31, 2026.
- The company issued a press release announcing those quarterly results; the press release is attached to the 8-K as Exhibit 99.1.
Key Details
- Filing date: March 12, 2026 (Form 8-K).
- Reporting item: Item 2.02 — Results of Operations and Financial Condition (unaudited Q3 results).
- Quarter covered: Third quarter ended January 31, 2026.
- Exhibit: Press release dated March 12, 2026 included as Exhibit 99.1.
Why It Matters
- This filing signals Champions Oncology has publicly released its latest quarterly earnings and operational results, which investors use to assess revenue, profitability, and trend direction.
- Investors should review the attached press release (Exhibit 99.1) and the company’s quarterly financial statements for specific revenue, earnings, and other metrics before making investment decisions.